Dr. Dino Prato describes a metastatic cancer patient given 2–3 months to live whose case didn't fit standard treatment. Instead of conventional therapy, his team used personalized immunotherapy to reactivate the patient's immune system. The patient went into sustained long-term remission.
A patient that had 2 to 3 months to live, a metastatic picture that didn't fit neatly into any protocol. But this person wasn't a statistic, and you're not either. We approached it going after the immune system to tackle this cancer, a plan designed to restore that body's anti-tumor surveillance, and now focusing on monitoring and targeting immunotherapy. Those 2 to 3 months turned into long-term remission. And if that doesn't wake us up, nothing else will.
